LEIDEN, The Netherlands--(BUSINESS WIRE)--GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD”).
IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback